SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-191162
Filing Date
2004-11-09
Accepted
2004-11-09 15:25:25
Documents
6
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 526046
2 SEPARATION AGREEMENT dex101.htm EX-10.1 63727
3 FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT DATED NOVEMBER 3, 2004 dex102.htm EX-10.2 32422
4 CERTIFICATION OF CEO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT dex311.htm EX-31.1 6251
5 CERTIFICATION OF CFO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT dex312.htm EX-31.2 6185
6 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT dex321.htm EX-32.1 4730
  Complete submission text file 0001193125-04-191162.txt   641699
Mailing Address 371 BEL MARIN KEYS BLVD STE 210 NOVATO CA 94949
Business Address 371 BEL MARIN KEYS BLVD STE 210 NOVATO CA 94949 4158846700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 041129310
SIC: 2834 Pharmaceutical Preparations